IRIS
NIGRO, Gerardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.421
NA - Nord America 5.448
AS - Asia 5.412
SA - Sud America 889
Continente sconosciuto - Info sul continente non disponibili 476
AF - Africa 66
OC - Oceania 5
Totale 24.717
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.955
US - Stati Uniti d'America 5.321
SG - Singapore 2.014
IE - Irlanda 1.353
CN - Cina 1.137
HK - Hong Kong 889
BR - Brasile 755
VN - Vietnam 667
FR - Francia 616
IT - Italia 533
GB - Regno Unito 510
DE - Germania 478
UA - Ucraina 395
KR - Corea 246
SE - Svezia 183
IN - India 150
FI - Finlandia 123
GR - Grecia 116
AR - Argentina 62
TR - Turchia 62
JP - Giappone 60
CA - Canada 52
MX - Messico 39
ID - Indonesia 33
AT - Austria 32
NL - Olanda 27
BD - Bangladesh 25
IQ - Iraq 23
ZA - Sudafrica 23
BE - Belgio 20
PL - Polonia 20
EC - Ecuador 19
CZ - Repubblica Ceca 16
EG - Egitto 12
UZ - Uzbekistan 12
ES - Italia 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
PK - Pakistan 10
PY - Paraguay 10
TH - Thailandia 10
CO - Colombia 9
MA - Marocco 9
SA - Arabia Saudita 9
CH - Svizzera 8
VE - Venezuela 8
JM - Giamaica 7
KE - Kenya 7
BO - Bolivia 6
HN - Honduras 6
EU - Europa 5
JO - Giordania 5
LB - Libano 5
NI - Nicaragua 5
PH - Filippine 5
PS - Palestinian Territory 5
UY - Uruguay 5
AL - Albania 4
BG - Bulgaria 4
MY - Malesia 4
PE - Perù 4
TN - Tunisia 4
AU - Australia 3
AZ - Azerbaigian 3
BH - Bahrain 3
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NO - Norvegia 3
PT - Portogallo 3
QA - Qatar 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
DO - Repubblica Dominicana 2
IL - Israele 2
LT - Lituania 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BS - Bahamas 1
CI - Costa d'Avorio 1
GE - Georgia 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 24.242
Salva come PNG Salva come JPEG
Città #
Moscow 2.862
Dublin 1.351
Santa Clara 950
Hong Kong 873
Singapore 811
Jacksonville 654
Chandler 518
San Jose 445
Ashburn 314
Seoul 241
Ho Chi Minh City 212
Princeton 191
Hefei 189
Hanoi 167
Medford 155
Bremen 147
Roxbury 145
Beijing 130
Dallas 101
Bengaluru 97
Ann Arbor 86
The Dalles 83
Wilmington 82
Boardman 78
São Paulo 66
San Mateo 63
Caserta 56
Da Nang 52
Naples 51
New York 50
Cambridge 45
Des Moines 44
Nuremberg 44
Woodbridge 44
Munich 43
Falkenstein 34
Haiphong 34
Los Angeles 33
Belo Horizonte 32
Guangzhou 26
Jinan 25
Orem 25
Phoenix 25
Milan 23
Nanjing 23
Aversa 22
Atlanta 20
Düsseldorf 20
Nanchang 20
Houston 19
Rio de Janeiro 19
Brussels 18
Tianjin 18
Council Bluffs 17
Frankfurt am Main 17
Mountain View 17
Chicago 16
Helsinki 16
Norwalk 15
Tokyo 15
Brooklyn 14
Hangzhou 14
Mexico City 14
Shenyang 14
Warsaw 14
Zhengzhou 14
Brno 13
Changsha 13
London 13
Rome 13
Amsterdam 12
Hebei 12
Manchester 12
Redwood City 12
Biên Hòa 11
Brasília 11
Lanzhou 11
Memphis 11
Montreal 11
Shanghai 11
Turku 11
Vienna 11
Chennai 10
Columbus 10
Guarulhos 10
Marano Di Napoli 10
Mumbai 10
Napoli 10
Ninh Bình 10
Porto Alegre 10
Salvador 10
Taizhou 10
Tashkent 10
Buenos Aires 9
Ercolano 9
Guayaquil 9
Lappeenranta 9
Taiyuan 9
Toronto 9
Bangkok 8
Totale 12.433
Salva come PNG Salva come JPEG
Nome #
A longitudinal study on BIO14.6 hamsters with dilated cardiomyopathy: Micro-echocardiographic evaluation 185
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 168
Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol 167
Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology 166
Cardiovascular Involvement in mtDNA Disease: Diagnosis, Management, and Therapeutic Options 166
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 165
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 159
Anaesthesia and Rare Neuromuscular Diseases 157
Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy 155
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 154
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 152
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 150
Increased heterogenity of ventricular repolarization in obese nonhypertensive children 148
P dispersion: a new electrocardiographic parameter to evaluate the risk of atrial arrhythmias in Emery-Dreifuss muscular dystrophies 148
Apixaban in a morbid obese patient with atrial fibrillation: A clinical experience using the plasmatic drug evaluation 148
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients 148
Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation 147
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 147
Novel mutations in LMNA A/C gene and associated phenotypes 146
Arrhythmias and sudden cardiac death in beta-thalassemia major patients: Noninvasive diagnostic tools and early markers 146
Cardiomyopathies associated with Muscular Dystrophies 145
Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 142
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 142
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy 141
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 141
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 140
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 140
Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. 140
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 138
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 138
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 138
Ablate and pace: Comparison of outcomes between conduction system pacing and biventricular pacing 137
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death 137
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 137
DUAL PATHWAY INHIBITION WITH RIVAROXABAN AND ASPIRIN REDUCES INFLAMMATORY BIOMARKERS IN ATHEROSCLEROSIS 134
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. 134
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 134
The Impact of Selection Criteria of Obese Patients on Evaluation of Heart Rate Variability Following Bariatric Surgery Weight Loss 133
La variabilità del ciclo R-R come indice predittivo di effetto sul ritmo cardiaco in soggetti professionalmente esposti ai campi elettromagnetici ELF 133
Risk of arrhythmias in MYotonic Dystrophy: trial design of the RAMYD study 131
Familial dilated cardiomyopathy associated with the typical dystrophin BMD mutation. Report on two additional cases 131
Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. 130
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. 129
Advances in basic and clinical research in laminopathies. 129
Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach 129
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 128
Arrhythmic risk in Steinert Disease 128
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 128
Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene 128
Ginkgo biloba: an ancient tree with new arrhythmic side effects. 127
Usefulness of Heart Rate Variability as a predictor of sudden cardiac death in muscular dystrophies 127
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 126
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 126
Remote monitoring of implantable cardiac monitors in patients with unexplained syncope: Predictors of false‐positive alert episodes 125
Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry 125
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 125
Which parameters describe the electrophysiological properties of successful slow pathway RF ablation in patients with common atrioventricular nodal reentrant tachycardia? 125
Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatments 125
P3.14 New AAVs for the muscle gene therapy in sarcoglycan deficient animals 124
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies 123
Appropriate ICD Interventions for Ventricular Arrhythmias Are Predicted by Higher Syntax Scores I and II in Patients with Ischemic Heart Disease 123
Evaluation of the antioxidant response in the plasma of healthy or hypertensive subjects after short-term exercise 122
The QT dispersion in the risk stratification of sudden death in Becker patients 121
The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term follow-up study. 120
Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient. 116
ST-segment displacement in Duchenne muscular dystrophy: myocardial necrosis or apoptosis? 116
Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. 115
Heart involvement in Emery-Dreifuss muscular dystrophies: new parameters to detect early atrial fibrosis and vulnerability 115
Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study 115
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown 114
Idiopathic left ventricular tachycardia: Evidence of a his bundle 'bystander' participation 113
Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications: Results From the POINTED Registry 113
Asystole on loop recorder in patients with unexplained syncope and negative tilt testing: age distribution and clinical predictors 112
Risk of arrhythmia in type I Myotonic Dystrophy: the role of clinical and genetic variables 112
Ischemic heart disease therapy in the elderly: Risk/benefit ratio 111
Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients 111
Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results 111
Atrioventricular Interval Extension Is Highly Efficient in Preventing Unnecessary Right Ventricular Pacing in Sinus Node Disease: A Randomized Cross-Over Study Versus Dual- to Atrial Single-Chamber Mode Switch 111
Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors 110
Evaluation of thyroid dysfunction in patients with paroxysmal atrial fibrillation 108
Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patient 108
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols 107
Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients 107
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients 107
Prevalence and clinical predictors of vasodepressor syncope during head up tilt test 106
Rate and nature of complications with leadless transcatheter pacemakers compared with transvenous pacemakers: results from an Italian multicentre large population analysis 106
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study 106
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 105
HETEROGENEITY OF VENTRICULAR REPOLARIZATION IN SEVERE AORTIC COARCTATION NEWBORNS 104
La variabilità del ciclo R-R come indice predittivo di effetto sul ritmo cardiaco in soggetti professionalmente esposti a campi elettromagnetici ELF. Atti del 64° Congresso Nazionale SIMLII 104
The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients 104
Evaluation of Becker cardiomyopathy by Vest investigation 103
Autonomic nervous system modulation before the onset of sustained atrioventricular nodal reentry tachycardia. 103
Use of a lower dosage liver-Detargeted AAV vector to prevent hamster muscular dystrophy. 103
Superselective cannulation of coronary sinus branch with telescopic system during left ventricular lead placement 103
X-Linked Emery-Dreifuss Muscular Dystrophy: Study Of X-Chromosome Inactivation and Its Relation with Clinical Phenotypes in Female Carriers. 103
Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response 102
Interazione tra campi elettromagnetici ELF e ritmo cardiaco in macchinisti di veicoli a trazione elettrica: ricerca di un indice predittivo di rischio aritmico 102
Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study 102
The Controversial Epidemiology of Left Ventricular Dysfunction in Patients With Myotonic Dystrophy Type 1 101
Totale 12.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.244
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.261 0 26 52 48 400 4 10 36 43 191 96 355
2022/20232.296 222 43 23 175 263 160 7 111 1.204 21 37 30
2023/2024848 55 39 38 65 343 32 15 21 4 17 60 159
2024/20253.461 19 27 15 73 503 560 340 279 452 697 270 226
2025/202613.369 526 660 740 768 1.030 7.414 836 405 474 236 200 80
2026/2027341 109 232 0 0 0 0 0 0 0 0 0 0
Totale 24.717